Neurorecovery - When evidence from the bench meets results at the bedside
ON DEMAND Published on October 18, 2022 at 12:00 - 13:00 CET
The two speakers will outline – from a clinicians perspective – which aspects of Cerebrolysin’s mode of action are proven and tested in clinical practice; we will hear about successful treatments in severe TBI and in acute stroke.
Join the webinar and register now!
Duration: 1 hour
Languages: Webinar will be held in English language incl. subtitles if requested and Russian simultaneous translation will be offered.
Andrei AlexandrovChair of the Department of Neurology and Semmes-Murphey Professor at the University of Tennessee, USA
Helmut TrimmelHead of Anaesthesia, Emergency and General Intensive Care Medicine
Landesklinikum Wiener Neustadt, Austria